A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles
暂无分享,去创建一个
Konrad Hungerbühler | Natalie von Goetz | K. Hungerbühler | N. von Goetz | G. Bachler | Gerald Bachler
[1] Samir Mitragotri,et al. Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.
[2] L. Ji,et al. Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity. , 1992, Journal of applied physiology.
[3] K Hungerbühler,et al. Characterization of silver release from commercially available functional (nano)textiles. , 2012, Chemosphere.
[4] K. Avgoustakis,et al. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content , 2012, International journal of nanomedicine.
[5] S. Sano,et al. Absorption, excretion and tissue distribution of silver sulphadiazine. , 1982, Burns, including thermal injury.
[6] B. Latenser. Silver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressing , 2010 .
[7] T. Turner,et al. Influence of surgically induced varicocele on testicular blood flow, temperature, and histology in adult rats and dogs. , 1981, The Journal of clinical investigation.
[8] Christian Mühlfeld,et al. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. , 2010, Small.
[9] E. Rummeny,et al. Monitoring radiation‐induced changes in bone marrow histopathology with ultra‐small superparamagnetic iron oxide (USPIO)‐enhanced MRI , 1999, Journal of magnetic resonance imaging : JMRI.
[10] J. Valentin. Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.
[11] U. Heinzmann,et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. , 2001, Environmental health perspectives.
[12] E. Lissi,et al. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. , 2001, Archives of biochemistry and biophysics.
[13] Jin Sik Kim,et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. , 2008, Inhalation toxicology.
[14] Kyunghee Choi,et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. , 2010, Environmental toxicology and pharmacology.
[15] R. MacCuspie,et al. Colloidal stability of silver nanoparticles in biologically relevant conditions , 2011 .
[16] Z. Chai,et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. , 2007, Toxicology letters.
[17] J. Winther,et al. Quantifying the global cellular thiol–disulfide status , 2009, Proceedings of the National Academy of Sciences.
[18] M. Stoltenberg,et al. Cultured macrophages cause dissolucytosis of metallic silver. , 2009, Histology and histopathology.
[19] S. Davis,et al. Targeting of colloidal particles to the bone marrow. , 1987, Life sciences.
[20] K. Bader. Organ Deposition of Silver Following Silver Nitrate Therapy of Burns , 1966, Plastic and reconstructive surgery.
[21] Furchner Je,et al. Comparative metabolism of radionuclides in mammals-IV. Retention of silver-110m in the mouse, rat, monkey, and dog. , 1968 .
[22] Linsey C Marr,et al. Silver nanoparticles and total aerosols emitted by nanotechnology-related consumer spray products. , 2011, Environmental science & technology.
[23] C. P. Yu,et al. A dosimetry model of nickel compounds in the rat lung. , 1999, Inhalation toxicology.
[24] J. Willson,et al. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. , 1994, Cancer research.
[25] Melvin E. Andersen,et al. Physiologically Based Pharmacokinetic Modeling : Science and Applications , 2005 .
[26] A. Allen,et al. Dispersion stabilization of silver nanoparticles in synthetic lung fluid studied under in situ conditions , 2011, Nanotoxicology.
[27] Alexander M Seifalian,et al. Nanosilver as a new generation of nanoproduct in biomedical applications. , 2010, Trends in biotechnology.
[28] S. Oldenburg,et al. Evaluation of Silver Nanoparticle Toxicity in Skin in Vivo and Keratinocytes in Vitro , 2009, Environmental health perspectives.
[29] Ting Zhang,et al. Acute toxic effects and gender‐related biokinetics of silver nanoparticles following an intravenous injection in mice , 2012, Journal of applied toxicology : JAT.
[30] J. Wilkinson,et al. Comparison of male reproductive parameters in three rat strains: Dark Agouti, Sprague-Dawley and Wistar , 2000, Laboratory animals.
[31] Stephen M. Roberts,et al. Differential binding of serum proteins to nanoparticles , 2008 .
[32] L. Edward Gaul,et al. CLINICAL SPECTROSCOPY: SEVENTY CASES OF GENERALIZED ARGYROSIS FOLLOWING ORGANIC AND COLLOIDAL SILVER MEDICATION, INCLUDING A BIOSPECTROMETRIC ANALYSIS OF TEN CASES , 1935 .
[33] D. Klee,et al. Influence of particle size and material properties on mucociliary clearance from the airways. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[34] Vicki Stone,et al. Nano-silver – feasibility and challenges for human health risk assessment based on open literature , 2010, Nanotoxicology.
[35] M. Fung,et al. Systemic argyria associated with ingestion of colloidal silver. , 2005, Dermatology online journal.
[36] R. Hurt,et al. Controlled release of biologically active silver from nanosilver surfaces. , 2010, ACS nano.
[37] K. Hungerbühler,et al. Migration of silver from commercial plastic food containers and implications for consumer exposure assessment , 2013, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[38] N. Ballatori,et al. Biliary secretion of glutathione and of glutathione-metal complexes. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[39] X. Chen,et al. Nanosilver: a nanoproduct in medical application. , 2008, Toxicology letters.
[40] R. Burrell,et al. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. , 1999, The Journal of burn care & rehabilitation.
[41] H. Autrup,et al. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. , 2009, Toxicology letters.
[42] Susan E. Dunn,et al. Microspheres for targeting drugs to specific body sites , 1993 .
[43] A. Lansdown. Silver in Healthcare: Its Antimicrobial Efficacy and Safety in Use , 2010 .
[44] I. Zuhorn,et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.
[45] Pratim Biswas,et al. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies , 2009 .
[46] Kwangsik Park,et al. Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats , 2011, Archives of pharmacal research.
[47] Harold Blumberg,et al. ARGYREMIA: DETECTION OF UNSUSPECTED AND OBSCURE ARGYRIA BY THE SPECTROGRAPHIC DEMONSTRATION OF HIGH BLOOD SILVER , 1934 .
[48] COMPARATIVE METABOLISM OF RADIONUCLIDES IN MAMMALS: A REVIEW. , 1971 .
[49] I. Yu,et al. A health surveillance case study on workers who manufacture silver nanomaterials , 2012, Nanotoxicology.
[50] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[51] R. van Furth,et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. , 1972, Bulletin of the World Health Organization.
[52] M. Kruszewski,et al. Time‐dependent biodistribution and excretion of silver nanoparticles in male Wistar rats , 2012, Journal of applied toxicology : JAT.
[53] U. Vogel,et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate , 2011, Particle and Fibre Toxicology.
[54] G. Bachand,et al. Cytotoxicity and inflammation in human alveolar epithelial cells following exposure to occupational levels of gold and silver nanoparticles , 2012, Journal of Nanoparticle Research.
[55] H. Calvin,et al. High levels of glutathione attained during postnatal development of rat testis. , 1982, The Journal of experimental zoology.
[56] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.
[57] T. Higuchi,et al. Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.
[58] Ulrike Blume-Peytavi,et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. , 2006, The Journal of investigative dermatology.
[59] Abderrahim Nemmar,et al. Development of a physiologically based kinetic model for 99m-Technetium-labelled carbon nanoparticles inhaled by humans , 2009, Inhalation toxicology.
[60] Robert Landsiedel,et al. Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.
[61] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[62] A. R. Cooper,et al. The composition of the adult human body as determined by chemical analysis. , 1953, The Journal of biological chemistry.
[63] D. W. Potter,et al. Apparent rates of glutathione turnover in rat tissues. , 1993, Toxicology and applied pharmacology.
[64] Jim E Riviere,et al. Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model. , 2009, Nano letters.
[65] Hemant Sarin,et al. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability , 2010, Journal of angiogenesis research.
[66] R. Reiter,et al. One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species? , 2007, Journal of pineal research.
[67] H. Autrup,et al. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 , 2011, Archives of Toxicology.
[68] J. Aaseth,et al. Hepatobiliary transport and organ distribution of silver in the rat as influenced by selenite. , 1981, Toxicology.
[69] C. Richmond,et al. Comparative metabolism of radionuclides in mammals-IV. Retention of silver-110m in the mouse, rat, monkey, and dog. , 1968, Health physics.
[70] J. R. Kramer,et al. Structural chemistry and geochemistry of silver‐sulfur compounds: Critical review , 1999 .
[71] Kelly G Pennell,et al. Kinetics and mechanisms of nanosilver oxysulfidation. , 2011, Environmental science & technology.
[72] Massimo Bovenzi,et al. Human skin penetration of cobalt nanoparticles through intact and damaged skin. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[73] Massimo Bovenzi,et al. Human skin penetration of silver nanoparticles through intact and damaged skin. , 2009, Toxicology.
[74] Gregory V Lowry,et al. Sulfidation processes of PVP-coated silver nanoparticles in aqueous solution: impact on dissolution rate. , 2011, Environmental science & technology.
[75] M. Yoneda,et al. Whole-body distribution of 14C-labeled silica nanoparticles and submicron particles after intravenous injection into Mice , 2012, Journal of Nanoparticle Research.
[76] A. Isab,et al. Synthesis and characterization of thiolate-Ag(I) complexes by solid-state and solution NMR and their antimicrobial activity. , 2007, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[77] Icrp. Human Respiratory Tract Model for Radiological Protection , 1994 .
[78] P. Drake,et al. Exposure-related health effects of silver and silver compounds: a review. , 2005, The Annals of occupational hygiene.
[79] Sang-Ho Kim,et al. Ion‐release kinetics and ecotoxicity effects of silver nanoparticles , 2012, Environmental toxicology and chemistry.
[80] J. Wahlberg,et al. A COMPARATIVE INVESTIGATION OF THE PERCUTANEOUS ABSORPTION OF METAL COMPOUNDS IN THE GUINEA PIG BY MEANS OF THE RADIOACTIVE ISOTOPES: 51CR, 58CO, 65ZN, 110MAG, 115MCD, 203HG. , 1964, The Journal of investigative dermatology.
[81] Rudolf Hagen,et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. , 2011, Toxicology letters.
[82] A. Svardal,et al. Glutathione content in human bone marrow and circadian stage relation to DNA synthesis. , 1991, Journal of the National Cancer Institute.
[83] M. Epple,et al. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs) , 2009, Langenbeck's Archives of Surgery.
[84] Hans Bouwmeester,et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. , 2011, ACS nano.
[85] M. Stoltenberg,et al. Uptake of silver from metallic silver surfaces induces cell death and a pro-inflammatory response in cultured J774 macrophages. , 2011, Histology and histopathology.
[86] Taesung Kim,et al. Lung Function Changes in Sprague-Dawley Rats After Prolonged Inhalation Exposure to Silver Nanoparticles , 2008, Inhalation toxicology.
[87] Samir Mitragotri,et al. Macrophages Recognize Size and Shape of Their Targets , 2010, PloS one.
[88] H. Bouwmeester,et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. , 2012, ACS nano.
[89] N. Makino,et al. Glutathione Induces Neuronal Differentiation in Rat Bone Marrow Stromal Cells , 2007, Neurochemical Research.
[90] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[91] C. Klaassen. Biliary excretion of silver in the rat, rabbit, and dog. , 1979, Toxicology and applied pharmacology.
[92] H. Bouwmeester,et al. Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model , 2012, Nanotoxicology.
[93] J. Jung,et al. Twenty-Eight-Day Inhalation Toxicity Study of Silver Nanoparticles in Sprague-Dawley Rats , 2007, Inhalation toxicology.
[94] Anoop Kumar Sharma,et al. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. , 2012, Neurotoxicology.
[95] A. Proia,et al. Corneal argyrosis associated with silver soldering. , 1992, Cornea.
[96] L Burnett,et al. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens , 1996, The Australasian journal of dermatology.
[97] Dieter Braun,et al. The toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration range , 2012 .
[98] Anne Lynn S Chang,et al. A case of argyria after colloidal silver ingestion , 2006, Journal of cutaneous pathology.
[99] Michigan.,et al. Toxicological profile for dichloropropenes , 2008 .
[100] Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. , 1994, Annals of the ICRP.
[101] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[102] F. Scafa,et al. Ocular Argyrosis in a Silver Craftsman , 2008, Journal of occupational health.
[103] G. Divincenzo,et al. Biologic monitoring of workers exposed to silver , 1985, International archives of occupational and environmental health.
[104] W. D. de Jong,et al. Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment , 2009 .
[105] Jianmin Chen,et al. Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. , 2006, Toxicology.
[106] Cihan Göktan,et al. Effect of Varicocele on Testicular Artery Blood Flow in Men Color Doppler Investigation , 2003, Scandinavian journal of urology and nephrology.
[107] Jürgen Seitz,et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs , 2009, Inhalation toxicology.
[108] K Hungerbühler,et al. Migration of Ag- and TiO2-(Nano)particles from textiles into artificial sweat under physical stress: experiments and exposure modeling. , 2013, Environmental science & technology.
[109] G. Lowry,et al. Environmental transformations of silver nanoparticles: impact on stability and toxicity. , 2012, Environmental science & technology.
[110] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[111] T. Higuchi. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.
[112] J. Kreuter. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. , 2004, Journal of nanoscience and nanotechnology.
[113] I. Yu,et al. Histological Study of Gender Differences in Accumulation of Silver Nanoparticles in Kidneys of Fischer 344 Rats , 2009, Journal of toxicology and environmental health. Part A.
[114] G. Danscher. Light and electron microscopic localization of silver in biological tissue , 2004, Histochemistry.
[115] L. Packer,et al. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. , 1994, The Journal of investigative dermatology.
[116] G. Piolatto,et al. Tentative reference values for gold, silver and platinum: literature data analysis. , 1992, The Science of the total environment.
[117] Y Li,et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[118] Gunnar F. Nordberg,et al. Handbook on the Toxicology of Metals , 1979 .
[119] W. D. de Jong,et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.
[120] C. P. Rhoads,et al. A Contribution to the Pathology of Generalized Argyria with a Discussion of the Fate of Silver in the Human Body. , 1927, The American journal of pathology.
[121] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[122] C. L. Fox. Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. , 1968, Archives of surgery.
[123] Dwight Romanovicz,et al. Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. , 2010, Metallomics : integrated biometal science.
[124] B. W. East,et al. Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti‐smoking remedy containing silver acetate , 1980, Clinical and experimental dermatology.